ILMN - Illumina - Stock Forecast

Coverage Profile Stock analysts Price Targets & Ratings Chart Insider Trading

ILMN is currently covered by 19 analysts with an average price target of $145.57. This is a potential upside of $29.48 (25.39%) from yesterday's end of day stock price of $116.09.

Illumina's activity chart (see below) currently has 320 price targets and 269 ratings on display. The stock rating distribution of ILMN is 39.29% HOLD, 51.19% BUY and 9.52% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 75.65% with an average time for these price targets to be met of 208.07 days.

Highest price target for ILMN is $200, Lowest price target is $80, average price target is $145.57.

Most recent stock forecast was given by MASON CARRICO from STEPHENS on 10-Jul-2024.

Overview

Illumina is a life science tools and integrated systems company that focuses on large-scale analysis of genetic variation and function. The company operates through two segments, Core Illumina and GRAIl:

  • The Core Illumina segment develops and markets genomic analysis products and services. This segment’s products are used for applications such as cancer research, reproductive and genetic health, and agriculture.
  • The GRAIL segment focuses on developing multi-cancer early detection tests using Illumina’s sequencing technology. The GRAIL segment aims to develop blood tests that can detect multiple types of cancer at an early stage.

The company’s Galleri test is a multi-cancer early detection test that can detect more than 50 types of cancer through a simple blood draw.

In addition to its products, Illumina provides a range of services including whole-genome sequencing, genotyping, non-invasive prenatal testing (NIPT), and product support services.

History

Illumina was incorporated in 1998 and is headquartered in San Diego, California.

Currently out of the existing stock ratings of ILMN, 33 are a HOLD (39.29%), 43 are a BUY (51.19%), 8 are a SELL (9.52%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

170

$53.91 (46.44%)

170

4 days ago

0/4 (0%)

$56.83 (50.22%)

Buy

175

$58.91 (50.75%)

160

1 months 3 days ago

4/11 (36.36%)

$62.41 (55.43%)

128

Buy

176

$59.91 (51.61%)

2 months 8 days ago

2/6 (33.33%)

$57.02 (47.92%)

29

Sell

80

$-36.09 (-31.09%)

100

5 months 19 days ago

8/9 (88.89%)

$-62.76 (-43.96%)

201

Hold

130

$13.91 (11.98%)

120

5 months 28 days ago

2/16 (12.5%)

$-5.14 (-3.80%)

46

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ILMN (Illumina) average time for price targets to be met?

On average it took 208.07 days on average for the stock forecasts to be realized with a an average price target met ratio 75.65

Which analyst has the current highest performing score on ILMN (Illumina) with a proven track record?

LUKE SERGOTT

Which analyst has the most public recommendations on ILMN (Illumina)?

Luke Sergott works at BARCLAYS and has 18 price targets and 11 ratings on ILMN

Which analyst is the currently most bullish on ILMN (Illumina)?

Steven Mah with highest potential upside - $443.91

Which analyst is the currently most reserved on ILMN (Illumina)?

Luke Sergott with lowest potential downside - -$36.09

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?